Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ross

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The American Journal of Psychiatry|June 15, 2022
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic PainDeborah S Hasin, Dvora Shmulewitz, Malka Stohl, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
BMJ Open|August 24, 2023
Safer medicines To reduce falls and refractures for OsteoPorosis (#STOP): a study protocol for a randomised controlled trial of medical specialist-initiated pharmacist-led medication management reviews in primary careRebekah Jane Moles, Lin Perry, Justine M Naylor, et al.
Addiction (Abingdon, England)|March 8, 2016
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyWalter Ling, Maureen P Hillhouse, Andrew J Saxon, et al.
Plos Pathogens|June 24, 2022
Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Plos Pathogens|February 4, 2022
Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
BMJ Open|June 18, 2025
Timely post-discharge medication reviews to Improve Continuity-the Transitions Of Care stewardship (TIC TOC) study in rural and regional Australia: a parallel-group randomised controlled trial study protocolJonathan Penm, Kingston Yeung, Rebekah Jane Moles, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
The Journal of Laryngology and Otology|March 14, 2024
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth EditionJarrod J Homer, Stuart C Winter, Elizabeth C Abbey, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The American Journal of Psychiatry|June 15, 2022
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic PainDeborah S Hasin, Dvora Shmulewitz, Malka Stohl, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
BMJ Open|August 24, 2023
Safer medicines To reduce falls and refractures for OsteoPorosis (#STOP): a study protocol for a randomised controlled trial of medical specialist-initiated pharmacist-led medication management reviews in primary careRebekah Jane Moles, Lin Perry, Justine M Naylor, et al.
Addiction (Abingdon, England)|March 8, 2016
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyWalter Ling, Maureen P Hillhouse, Andrew J Saxon, et al.
Plos Pathogens|June 24, 2022
Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
Plos Pathogens|February 4, 2022
Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.
BMJ Open|June 18, 2025
Timely post-discharge medication reviews to Improve Continuity-the Transitions Of Care stewardship (TIC TOC) study in rural and regional Australia: a parallel-group randomised controlled trial study protocolJonathan Penm, Kingston Yeung, Rebekah Jane Moles, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
The Journal of Laryngology and Otology|March 14, 2024
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth EditionJarrod J Homer, Stuart C Winter, Elizabeth C Abbey, et al.
Pageof 8